key: cord-0851319-4jd6r0lj
authors: Sung, Pil S.; Oh, Jung S.; Choi, Joon‐Il
title: Acute Budd‐Chiari syndrome with thrombotic thrombocytopenia after BNT162b2 mRNA vaccination
date: 2022-03-21
journal: Liver Int
DOI: 10.1111/liv.15242
sha: 17d25c16195428b99217be010b3aa9fba126b19a
doc_id: 851319
cord_uid: 4jd6r0lj

nan

A 34-year-old female visited the clinic with increased abdominal circumference and pitting oedema of the lower extremities for 3 weeks. Liver enzymes were within the normal range on the laboratory examinations several months ago. She was not receiving oral contraceptives or hormone replacement. Importantly, she re- BCS is defined as the obstruction of hepatic venous outflow, and clinical findings develop rapidly over a few weeks in the acute form, with ascites and possible liver injury without collateral veins. 1 

An update on the Management of Budd-Chiari Syndrome

Clinical features of vaccineinduced immune thrombocytopenia and thrombosis

Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline

Unusual fever, headache, and abdominal pain in a healthy woman

Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study

Thrombosis with thrombocytopenia after the messenger RNA-1273 vaccine